Exchange: NASDAQ·Updated 04:33 AM EDT
News
all
press releases
What'sGoing On With AbCellera Biologics Stock On Tuesday?
AbCellera Biologics stock gains as investors react to Jazz Pharmaceuticals' FDA approval and the companies' antibody partnership.read more...
Benzinga
More News
Monday 8/17 Insider Buying Report: ABCL, BPRN
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At AbCellera Biologics, a filing with the SEC revealed that on Wednesday, Director...
Nasdaq News: Markets
AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants
AbCellera Biologics Inc. (Nasdaq: ABCL) (AbCellera) today announced the pricing of its oversubscribed underwritten public offering of 17,435,897 common shares at a price to the public of $9.75 per share and, in lieu of common shares to certain investors, pre-funded warrants to purchase up to...
Business Wire
What's Going on With AbCellera Biologics Stock On Wednesday?
AbCellera shares rise after positive ABCL635 Phase 2 results, while bullish momentum and analyst price targets point to further upside.read more...
Benzinga
National CineMedia Posts Downbeat Q2 Results, Joins Borr Drilling, AbCellera Biologics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures higher, Nasdaq 100 up 150 pts. National CineMedia shares down 16.4% on weak Q2 results and Captivate Holdings acquisition. Other stocks also falling in pre-market trading.read more...
Benzinga
AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
AbCellera Biologics Inc. (Nasdaq: ABCL) (AbCellera) today announced that it has commenced an underwritten public offering of $200.0 million of its common shares and, in lieu of common shares to certain investors, pre-funded warrants to purchase its common shares. All of the common shares and...
Business Wire
These Have the Market Hot Zone Setups
Planet Green Holdings (NYSEAMERICAN:PLAG), NeOnc Technologies (NASDAQ:NTHI), and Quantum Corporation (NASDAQ:QMCO) made nice runs since our midday coverage. While AbCellera Biologics (NASDAQ:ABCL) and Bank of America (NYSE:BAC) were among the notable names reaching new 52-week highs Tuesday.
24-7 Market News
Company News for Aug 11, 2026
Companies In The Article Are:BA,INTC,HZO,ABCL and ACHR
Zacks
Why Did ABCL, REPL, ABNB Stocks Hit 52-Week Highs Today?
AbCellera, Replimune and Airbnb reached fresh highs as strong drug data, new funding and better-than-expected earnings boosted investor confidence.
Stocktwits
AbCellera Biologics Menopause Drug Data Shows 'New Efficacy Benchmark'
AbCellera reports positive Phase 2 clinical trial results for ABCL635, a single-dose treatment for menopausal hot flashes.read more...
Benzinga

Advertisement|Remove ads.